Top

Published in:

Open Access 01-12-2017 | Research article

Long acting β₂-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection

Authors: Keiji Yamanashi, Satoshi Marumo, Ryota Sumitomo, Tsuyoshi Shoji, Motonari Fukui, Toshiro Katayama, Cheng-long Huang

Published in: Journal of Cardiothoracic Surgery | Issue 1/2017

Abstract

Background

Long-acting β₂-adrenoceptor agonists have been shown to increase the risk of atrial arrhythmias in patients with stable chronic obstructive pulmonary disease. The aim of this study was to investigate whether perioperative long-acting β₂-adrenoceptor agonists treatment would increase the risk of postoperative atrial arrhythmias after lung cancer surgery in chronic obstructive pulmonary disease patients.

Methods

We retrospectively analyzed 174 consecutive chronic obstructive pulmonary disease patients with non-small-cell lung cancer who underwent lobectomy or segmentectomy. The subjects were divided into those with or without perioperative long-acting β₂-adrenoceptor agonists treatment. Postoperative cardiopulmonary complications were compared between the two groups.

Results

There were no statistically significant differences between the perioperative long-acting β₂-adrenoceptor agonists treatment group and the control group in the incidence of postoperative atrial arrhythmias (P = 0.629). In 134 propensity-score–matched pairs, including variables such as age, gender, comorbidities, smoking history, operation procedure, lung-cancer staging, and respiratory function, there were no significant differences between the two groups in the incidence of postoperative cardiopulmonary complications, including atrial arrhythmias.

Conclusions

Perioperative administration of long-acting β₂-adrenoceptor agonists might not increase the incidence of postoperative atrial arrhythmias after surgical resection for non-small-cell lung cancer in chronic obstructive pulmonary disease patients.

Available only for authorised users

Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–85.CrossRefPubMed

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.CrossRefPubMed

Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–6.CrossRefPubMed

Curtis JJ, Parker BM, McKenney CA, Wagner-Mann CC, Walls JT, Demmy TL, et al. Incidence and predictors of supraventricular dysrhythmias after pulmonary resection. Ann Thorac Surg. 1998;66:1766–71.CrossRefPubMed

Sekine Y, Kesler KA, Behnia M, Brooks-Brunn J, Sekine E, Brown JW. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest. 2001;120:1783–90.CrossRefPubMed

Ritchie AJ, Bowe P, Gibbons JR. Prophylactic digitalization for thoracotomy: a reassessment. Ann Thorac Surg. 1990;50:86–8.CrossRefPubMed

Rena O, Papalia E, Oliaro A, Casadio C, Ruffini E, Filosso PL, et al. Supraventricular arrhythmias after resection surgery of the lung. Eur J Cardiothorac Surg. 2001;20:688–93.CrossRefPubMed

Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008;87:319–28.CrossRef

Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, et al. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med. 2013;173:1175–85.CrossRefPubMed

10.

Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, et al. B-type natriuretic Peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer. Ann Thorac Surg. 2011;92:1051–5.CrossRefPubMed

11.

Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Nakagiri T, et al. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery. Surg Today. 2014;44:285–90.CrossRefPubMed

12.

Yamanashi K, Marumo S, Shoji T, Fukui T, Sumitomo R, Otake Y, et al. The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg. 2015;63:652–9.CrossRefPubMed

13.

Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed

14.

Currie GP. Indacaterol Novartis/skyePharma. Curr Opin Investig Drugs. 2006;7:457–63.PubMed

15.

O’Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, et al. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med. 2011;105:1030–6.CrossRefPubMed

16.

Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994;105:753–9.CrossRefPubMed

17.

Suzuki H, Sekine Y, Yoshida S, Suzuki M, Shibuya K, Takiguchi Y, et al. Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study. Surg Today. 2010;40:923–30.CrossRefPubMed

18.

Ivanovic J, Maziak DE, Ramzan S, McGuire AL, Villeneuve PJ, Gilbert S, et al. Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection. Interact Cardiovasc Thorac Surg. 2014;18:340–6.CrossRefPubMed

19.

Iwata T, Nagato K, Nakajima T, Suzuki H, Yoshida S, Yoshino I. Risk factors predictive of atrial fibrillation after lung cancer surgery. Surg Today. 2016;46:877–86.CrossRefPubMed

Title: Long acting β2-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection
Authors: Keiji Yamanashi
Satoshi Marumo
Ryota Sumitomo
Tsuyoshi Shoji
Motonari Fukui
Toshiro Katayama
Cheng-long Huang
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Cardiothoracic Surgery / Issue 1/2017
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/s13019-017-0606-4

At a glance: The STEP trials

Springer Medicine

Long acting β₂-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Postcardiotomy VA-ECMO for refractory cardiogenic shock

Single-staged uniportal VATS in the supine position for simultaneous bilateral primary spontaneous pneumothorax

Spontaneous hemothorax caused by ruptured multiple mycotic aortic aneurysms: a case report and literature review

Left atrial myxoma complicated with multi-system embolization

The effect of preoperative liver dysfunction on cardiac surgery outcomes

Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome